Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amarin
Pharma
Top US lawyer urges SCOTUS to toss Amarin 'skinny label' case
As one feud over the carve-out known as “skinny” labeling ends, the U.S.' top lawyer is urging SCOTUS to reverse a recent ruling on another.
Fraiser Kansteiner
Feb 27, 2026 10:15am
SCOTUS to hear 'skinny label' case between Amarin, Hikma
Jan 20, 2026 11:54am
Amarin sells Vascepa's rights in Europe to Recordati for $25M
Jun 24, 2025 11:26am
Investor group calls for strategy shift at struggling Amarin
Mar 20, 2025 11:00am
Amarin, after stock crash and layoffs, revives patent lawsuit
Jun 26, 2024 1:01pm
Amarin's CEO resigns, leaving former interim chief to take over
Jun 4, 2024 11:19am
